{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:38:07Z","timestamp":1791067087119,"version":"4.1.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-024-00841-9","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T15:11:31Z","timestamp":1732893091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-5197","authenticated-orcid":false,"given":"Nanna M\u00f8ller","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-2039","authenticated-orcid":false,"given":"YuHong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Betzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4573-3131","authenticated-orcid":false,"given":"Sara","family":"Elfarrash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Shaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatus","family":"Krah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zagorka","family":"Vitic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalte","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Buchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Denham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio O.","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-8398","authenticated-orcid":false,"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4439-9020","authenticated-orcid":false,"given":"Poul Henning","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"841_CR1","doi-asserted-by":"crossref","unstructured":"Spillantini, M. G. & Goedert, M. The \u03b1-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N. Y. Acad. Sci. 920, 16\u201327 (2000).","DOI":"10.1111\/j.1749-6632.2000.tb06900.x"},{"key":"841_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau, L. M. L. et al. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 5, 525\u2013535 (2006).","journal-title":"Lancet Neurol."},{"key":"841_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"841_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. Mutation in the \u03b1-Synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"841_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger, R. et al. Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"841_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. Synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"841_CR7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364, 1167\u20131169 (2004).","journal-title":"Lancet"},{"key":"841_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J. J. et al. The new mutation, E46K, of \u03b1-Synuclein Causes Parkinson and lewy body dementia. Ann. Neurol. 55, 164\u2013173 (2004).","journal-title":"Ann. Neurol."},{"key":"841_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","volume":"22","author":"T Konno","year":"2016","unstructured":"Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W. & Wszolek, Z. K. Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat. Disord. 22, S1\u2013S6 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"841_CR10","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"2002","unstructured":"Wood, S. J. et al. Synuclein Fibrillogenesis is nucleation-dependent. J. Biol. Chem. 274, 19509\u201319512 (2002).","journal-title":"J. Biol. Chem."},{"key":"841_CR11","doi-asserted-by":"crossref","unstructured":"Wakabayashi, K., Tanji, K., Mori, F. & Takahashi, H. The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates. Neuropathology 27, 494\u2013506 (2007).","DOI":"10.1111\/j.1440-1789.2007.00803.x"},{"key":"841_CR12","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1073\/pnas.1604645113","volume":"113","author":"P Flagmeier","year":"2016","unstructured":"Flagmeier, P. et al. Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation. Proc. Natl Acad. Sci. USA 113, 10328\u201310333 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","volume":"9","author":"E Angot","year":"2010","unstructured":"Angot, E., Steiner, J. A., Hansen, C., Li, J. Y. & Brundin, P. Are synucleinopathies prion-like disorders? Lancet Neurol. 9, 1128\u20131138 (2010).","journal-title":"Lancet Neurol."},{"key":"841_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake, M. et al. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain 136, 1128\u20131138 (2013).","journal-title":"Brain"},{"key":"841_CR15","doi-asserted-by":"publisher","unstructured":"Prusiner, S. B. et al. Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1514475112 (2015).","DOI":"10.1073\/pnas.1514475112"},{"key":"841_CR16","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","volume":"37","author":"P Brundin","year":"2017","unstructured":"Brundin, P. & Melki, R. Prying into the prion hypothesis for parkinson\u2019s disease. J. Neurosci. 37, 9808\u20139818 (2017).","journal-title":"J. Neurosci."},{"key":"841_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"841_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., R\u00fcb, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"841_CR19","doi-asserted-by":"publisher","unstructured":"Terry, R. D. Do neuronal inclusions kill the cell? Adv. Dementia Res. 91\u201393, https:\/\/doi.org\/10.1007\/978-3-7091-6781-6_12. (2000).","DOI":"10.1007\/978-3-7091-6781-6_12"},{"key":"841_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1474-4422(04)00827-0","volume":"3","author":"CW Olanow","year":"2004","unstructured":"Olanow, C. W., Perl, D. P., DeMartino, G. N. & McNaught, K. S. P. Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 3, 496\u2013503 (2004).","journal-title":"Lancet Neurol"},{"key":"841_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.20321","volume":"57","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen, L., Kauppinen, T., Pirttil\u00e4, T., Autere, J. M. & Alafuzoff, I. \u03b1-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann. Neurol. 57, 82\u201391 (2005).","journal-title":"Ann. Neurol."},{"key":"841_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JPD-2011-11046","volume":"1","author":"L Parkkinen","year":"2011","unstructured":"Parkkinen, L. et al. Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson\u2019s disease. J. Parkinsons Dis. 1, 277\u2013286 (2011).","journal-title":"J. Parkinsons Dis."},{"key":"841_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-018-2854-6","volume":"373","author":"S Chartier","year":"2018","unstructured":"Chartier, S. & Duyckaerts, C. Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res. 373, 1\u201312 (2018).","journal-title":"Cell Tissue Res."},{"key":"841_CR24","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1021\/bi0102398","volume":"40","author":"MJ Volles","year":"2001","unstructured":"Volles, M. J. et al. Vesicle permeabilization by protofibrillar \u03b1-synuclein: Implications for the pathogenesis and treatment of Parkinson\u2019s disease. Biochemistry 40, 7812\u20137819 (2001).","journal-title":"Biochemistry"},{"key":"841_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267\u2013298 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"841_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","volume":"355","author":"MM Apetri","year":"2006","unstructured":"Apetri, M. M., Maiti, N. C., Zagorski, M. G., Carey, P. R. & Anderson, V. E. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. J. Mol. Biol. 355, 63\u201371 (2006).","journal-title":"J. Mol. Biol."},{"key":"841_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","volume":"111","author":"KM Danzer","year":"2009","unstructured":"Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G. & Hengerer, B. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J. Neurochem. 111, 192\u2013203 (2009).","journal-title":"J. Neurochem."},{"key":"841_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/BJ20111924","volume":"443","author":"MS Celej","year":"2012","unstructured":"Celej, M. S. et al. Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure. Biochem J. 443, 719\u2013726 (2012).","journal-title":"Biochem J."},{"key":"841_CR29","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149, 1048\u20131059 (2012).","journal-title":"Cell"},{"key":"841_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer, K. M. et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 7, 1\u201318 (2012).","journal-title":"Mol. Neurodegener."},{"key":"841_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24526","volume":"6","author":"L Pieri","year":"2016","unstructured":"Pieri, L., Madiona, K. & Melki, R. Structural and functional properties of prefibrillar \u03b1-synuclein oligomers. Sci. Rep. 6, 1\u201315 (2016).","journal-title":"Sci. Rep."},{"key":"841_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Alpha-synuclein oligomers: a new hope. Acta Neuropathol. 134, 819\u2013838 (2017).","journal-title":"Acta Neuropathol."},{"key":"841_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella, R. et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 12, 1\u201316 (2021).","journal-title":"Nat. Commun."},{"key":"841_CR34","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. et al. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc. Natl Acad. Sci. USA 108, 4194\u20134199 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science 358, 1440\u20131443 (2017).","journal-title":"Science"},{"key":"841_CR36","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots, I. et al. Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc. Natl Acad. Sci. USA 115, 7813\u20137818 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fnins.2016.00408","volume":"10","author":"M Ingelsson","year":"2016","unstructured":"Ingelsson, M. Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other lewy body disorders. Front. Neurosci. 10, 408 (2016).","journal-title":"Front. Neurosci."},{"key":"841_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jnc.14808","volume":"150","author":"P Alam","year":"2019","unstructured":"Alam, P., Bousset, L., Melki, R. & Otzen, D. E. \u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J. Neurochem. 150, 522\u2013534 (2019).","journal-title":"J. Neurochem."},{"key":"841_CR39","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.3390\/ijms21228645","volume":"21","author":"XY Du","year":"2020","unstructured":"Du, X. Y., Xie, X. X. & Liu, R. T. The role of \u03b1-Synuclein oligomers in Parkinson\u2019s Disease. Int. J. Mol. Sci. 21, 8645 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"841_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/JPD-201965","volume":"10","author":"R Kayed","year":"2020","unstructured":"Kayed, R., Dettmer, U. & Lesn\u00e9, S. E. Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk. J. Parkinsons Dis. 10, 791\u2013818 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"841_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","volume":"79","author":"NN Vaikath","year":"2015","unstructured":"Vaikath, N. N. et al. Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology. Neurobiol. Dis. 79, 81\u201399 (2015).","journal-title":"Neurobiol. Dis."},{"key":"841_CR42","doi-asserted-by":"crossref","unstructured":"Kumar, S. T. et al. How specific are the conformation-specific \u03b1-synuclein antibodies? Characterization and validation of 16 \u03b1-synuclein conformation-specific antibodies using well-characterized preparations of \u03b1-synuclein monomers, fibrils and oligomers with distinct struct. Neurobiol. Dis. 146, 105086 (2020).","DOI":"10.1016\/j.nbd.2020.105086"},{"key":"841_CR43","doi-asserted-by":"crossref","unstructured":"Outeiro, T. F. et al. Formation of toxic oligomeric \u03b1-synuclein species in living cells. PLoS ONE 3, e1867 (2008).","DOI":"10.1371\/journal.pone.0001867"},{"key":"841_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.tibs.2010.05.007","volume":"35","author":"SA Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves, S. A., Matos, J. E. & Outeiro, T. F. Zooming into protein oligomerization in neurodegeneration using BiFC. Trends Biochem. Sci. 35, 643\u2013651 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"841_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nbt0502-473","volume":"20","author":"S Fredriksson","year":"2002","unstructured":"Fredriksson, S. et al. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20, 473\u2013477 (2002).","journal-title":"Nat. Biotechnol."},{"key":"841_CR46","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","volume":"138","author":"RF Roberts","year":"2015","unstructured":"Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain. Brain 138, 1642\u20131657 (2015).","journal-title":"Brain"},{"key":"841_CR47","doi-asserted-by":"publisher","first-page":"e0196056","DOI":"10.1371\/journal.pone.0196056","volume":"13","author":"L Berkhoudt Lassen","year":"2018","unstructured":"Berkhoudt Lassen, L. et al. ELISA method to detect \u03b1-synuclein oligomers in cell and animal models. PLoS ONE 13, e0196056 (2018).","journal-title":"PLoS ONE"},{"key":"841_CR48","doi-asserted-by":"publisher","first-page":"e0216764","DOI":"10.1371\/journal.pone.0216764","volume":"14","author":"H Ruesink","year":"2019","unstructured":"Ruesink, H. et al. Stabilization of \u03b1-synuclein oligomers using formaldehyde. PLoS ONE 14, e0216764 (2019).","journal-title":"PLoS ONE"},{"key":"841_CR49","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","volume":"109","author":"K Vekrellis","year":"2009","unstructured":"Vekrellis, K., Xilouri, M., Emmanouilidou, E. & Stefanis, L. Inducible over-expression of wild type \u03b1-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. J. Neurochem. 109, 1348\u20131362 (2009).","journal-title":"J. Neurochem."},{"key":"841_CR50","doi-asserted-by":"publisher","first-page":"e44617","DOI":"10.15252\/embr.201744617","volume":"19","author":"C Betzer","year":"2018","unstructured":"Betzer, C. et al. Alpha\u2010synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Rep. 19, e44617 (2018).","journal-title":"EMBO Rep."},{"key":"841_CR51","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","volume":"18","author":"OMA El-Agnaf","year":"2004","unstructured":"El-Agnaf, O. M. A. et al. A strategy for designing inhibitors of \u03b1 \u2010synuclein aggregation and toxicity as a novel treatment for Parkinson\u2019s disease and related disorders. FASEB J. 18, 1315\u20131317 (2004).","journal-title":"FASEB J."},{"key":"841_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","volume":"137","author":"H Sekiya","year":"2019","unstructured":"Sekiya, H. et al. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol. 137, 455\u2013466 (2019).","journal-title":"Acta Neuropathol."},{"key":"841_CR53","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/jnr.24927","volume":"99","author":"A Behere","year":"2021","unstructured":"Behere, A. et al. Visualization of early oligomeric \u03b1-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]\u03b1-syn transgenic mouse model. J. Neurosci. Res. 99, 2525\u20132539 (2021).","journal-title":"J. Neurosci. Res."},{"key":"841_CR54","doi-asserted-by":"crossref","unstructured":"Sekiya, H. et al. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson\u2019s disease. Acta Neuropathol. Commun. 10, 133 (2022).","DOI":"10.1186\/s40478-022-01440-6"},{"key":"841_CR55","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9, J., Sharma, M. & S\u00fcdhof, T. C. \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl Acad. Sci. USA 111, E4274\u2013E4283 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107\u2013110 (2011).","journal-title":"Nature"},{"key":"841_CR57","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.bpj.2016.10.016","volume":"111","author":"A Iyer","year":"2016","unstructured":"Iyer, A., Schilderink, N., Claessens, M. M. A. E. & Subramaniam, V. Membrane-Bound Alpha Synuclein Clusters induce impaired lipid diffusion and increased lipid packing. Biophys. J. 111, 2440\u20132449 (2016).","journal-title":"Biophys. J."},{"key":"841_CR58","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1021\/cn3001312","volume":"4","author":"M Rabe","year":"2013","unstructured":"Rabe, M. et al. On-surface aggregation of \u03b1-synuclein at nanomolar concentrations results in two distinct growth mechanisms. ACS Chem. Neurosci. 4, 408\u2013417 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"841_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-Synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"841_CR60","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41531-024-00822-y","volume":"10","author":"I Liekni\u0146a","year":"2024","unstructured":"Liekni\u0146a, I. et al. Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2. npj Parkinsons Dis. 10, 206 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"841_CR61","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li, W. et al. Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc. Natl Acad. Sci. USA 102, 2162\u20132167 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR62","doi-asserted-by":"publisher","first-page":"13482","DOI":"10.1074\/jbc.M117.780296","volume":"292","author":"RJ Karpowicz","year":"2017","unstructured":"Karpowicz, R. J. et al. Selective imaging of internalized proteopathic \u03b1-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies. J. Biol. Chem. 292, 13482\u201313497 (2017).","journal-title":"J. Biol. Chem."},{"key":"841_CR63","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier, A. L. et al. The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc. Natl Acad. Sci. USA 117, 4971\u20134982 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"841_CR64","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s40478-019-0865-5","volume":"7","author":"S Elfarrash","year":"2019","unstructured":"Elfarrash, S. et al. Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates. Acta Neuropathol. Commun. 7, 213 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"841_CR65","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/sageke.2005.5.re1","volume":"2005","author":"DA Gray","year":"2005","unstructured":"Gray, D. A. & Woulfe, J. Lipofuscin and aging: a matter of toxic waste. Sci. Aging Knowledge Environ. 2005, re1 (2005).","journal-title":"Sci. Aging Knowledge Environ."},{"key":"841_CR66","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/pmic.201100668","volume":"12","author":"P Ottis","year":"2012","unstructured":"Ottis, P. et al. Human and rat brain lipofuscin proteome. Proteomics 12, 2445\u20132454 (2012).","journal-title":"Proteomics"},{"key":"841_CR67","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy, K. E. et al. Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson\u2019s disease. Brain 137, 834\u2013848 (2014).","journal-title":"Brain"},{"key":"841_CR68","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","volume":"33","author":"I Arganda-Carreras","year":"2017","unstructured":"Arganda-Carreras, I. et al. Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification. Bioinformatics 33, 2424\u20132426 (2017).","journal-title":"Bioinformatics"},{"key":"841_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding, A. J. & Halliday, G. M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 102, 355\u2013363 (2001).","journal-title":"Acta Neuropathol."},{"key":"841_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer, W. J. The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol. 120, 131\u2013143 (2010).","journal-title":"Acta Neuropathol."},{"key":"841_CR71","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/JNEUROSCI.2220-12.2012","volume":"32","author":"Y Nakata","year":"2012","unstructured":"Nakata, Y. et al. Accumulation of \u03b1-Synuclein triggered by presynaptic dysfunction. J. Neurosci. 32, 17186\u201317196 (2012).","journal-title":"J. Neurosci."},{"key":"841_CR72","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena, M. et al. Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies. Brain 140, 3204\u20133214 (2017).","journal-title":"Brain"},{"key":"841_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-04780-4","volume":"12","author":"S Awa","year":"2022","unstructured":"Awa, S. et al. Phosphorylation of endogenous \u03b1-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body. Sci. Rep. 12, 1\u201313 (2022).","journal-title":"Sci. Rep."},{"key":"841_CR74","doi-asserted-by":"crossref","unstructured":"Shaib, A. H. et al. One-step nanoscale expansion microscopy reveals individual protein shapes. Nat Biotechnol. 1-9 (2024).","DOI":"10.1038\/s41587-024-02431-9"},{"key":"841_CR75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jmb.2010.07.001","volume":"402","author":"EJ De Genst","year":"2010","unstructured":"De Genst, E. J. et al. Structure and properties of a complex of \u03b1-Synuclein and a single-domain camelid antibody. J. Mol. Biol. 402, 326\u2013343 (2010).","journal-title":"J. Mol. Biol."},{"key":"841_CR76","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/BF01217295","volume":"19","author":"A Peters","year":"1990","unstructured":"Peters, A. & Harriman, K. M. Different kinds of axon terminals forming symmetric synapses with the cell bodies and initial axon segments of layer II\/III pyramidal cells. I. Morphometric analysis. J. Neurocytol. 19, 154\u2013174 (1990).","journal-title":"J. Neurocytol."},{"key":"841_CR77","first-page":"4207","volume":"125","author":"N Mitchell","year":"2012","unstructured":"Mitchell, N. et al. Sonic hedgehog regulates presynaptic terminal size, ultrastructure and function in hippocampal neurons. J. Cell Sci. 125, 4207\u20134213 (2012).","journal-title":"J. Cell Sci."},{"key":"841_CR78","doi-asserted-by":"crossref","unstructured":"Nosov, G., Kahms, M. & Klingauf, J. The decade of super-resolution microscopy of the presynapse. Front. Synaptic Neurosci. 12, 32 (2020).","DOI":"10.3389\/fnsyn.2020.00032"},{"key":"841_CR79","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.1252884","volume":"344","author":"BG Wilhelm","year":"2014","unstructured":"Wilhelm, B. G. et al. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344, 1023\u20131028 (2014).","journal-title":"Science"},{"key":"841_CR80","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41592-018-0120-1","volume":"15","author":"RP Moore","year":"2018","unstructured":"Moore, R. P. & Legant, W. R. Improving probes for super-resolution. Nat. Methods 15, 659\u2013660 (2018).","journal-title":"Nat. Methods"},{"key":"841_CR81","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"C Lavedan","year":"1998","unstructured":"Lavedan, C. The synuclein family. Genome Res. 8, 871\u2013880 (1998).","journal-title":"Genome Res."},{"key":"841_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-021-02316-0","volume":"142","author":"N Ferreira","year":"2021","unstructured":"Ferreira, N. et al. Multiple system atrophy-associated oligodendroglial protein p25\u03b1 stimulates formation of novel \u03b1-synuclein strain with enhanced neurodegenerative potential. Acta Neuropathol. 142, 87\u2013115 (2021).","journal-title":"Acta Neuropathol."},{"key":"841_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00430-8","volume":"9","author":"SA Ferreira","year":"2023","unstructured":"Ferreira, S. A. et al. Sex-dimorphic neuroprotective effect of CD163 in an \u03b1-synuclein mouse model of Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 9, 1\u201321 (2023).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"841_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-024-01104-7","volume":"17","author":"T Ishimoto","year":"2024","unstructured":"Ishimoto, T. et al. A novel mouse model for investigating \u03b1-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy. Mol. Brain 17, 1\u201313 (2024).","journal-title":"Mol. Brain"},{"key":"841_CR85","doi-asserted-by":"publisher","first-page":"105966","DOI":"10.1016\/j.nbd.2022.105966","volume":"176","author":"J Estaun-Panzano","year":"2023","unstructured":"Estaun-Panzano, J., Arotcarena, M. L. & Bezard, E. Monitoring \u03b1-synuclein aggregation. Neurobiol. Dis. 176, 105966 (2023).","journal-title":"Neurobiol. Dis."},{"key":"841_CR86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M. & Pearce, R. K. B. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of \u03b1-synuclein staging. Neuropathol. Appl Neurobiol. 34, 284\u2013295 (2008).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"841_CR87","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen, L., Pirttil\u00e4, T. & Alafuzoff, I. Applicability of current staging\/categorization of \u03b1-synuclein pathology and their clinical relevance. Acta Neuropathol. 115, 399\u2013407 (2008).","journal-title":"Acta Neuropathol."},{"key":"841_CR88","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai, J., Brayne, C., McKeith, I., Matthews, F. & Ince, P. G. Patterns and stages of \u03b1-synucleinopathy. Neurology 70, 1042\u20131048 (2008).","journal-title":"Neurology"},{"key":"841_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-022-01468-8","volume":"10","author":"MF Altay","year":"2022","unstructured":"Altay, M. F., Liu, A. K. L., Holton, J. L., Parkkinen, L. & Lashuel, H. A. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol. Commun. 10, 1\u201318 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"841_CR90","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-First versus Gut-First Parkinson\u2019s Disease: a hypothesis. J. Parkinson\u2019s Dis. 9, S281\u2013S295 (2019).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"841_CR91","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager, J. et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143, 3077\u20133088 (2020).","journal-title":"Brain"},{"key":"841_CR92","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol. Dis. 161, 105557 (2021).","journal-title":"Neurobiol. Dis."},{"key":"841_CR93","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/JPD-212761","volume":"11","author":"K Knudsen","year":"2021","unstructured":"Knudsen, K. et al. Asymmetric Dopaminergic dysfunction in brain-first versus body-first Parkinson\u2019s Disease Subtypes. J. Parkinsons Dis. 11, 1677\u20131687 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"841_CR94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","volume":"31","author":"S Greffard","year":"2010","unstructured":"Greffard, S. et al. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol. Aging 31, 99\u2013103 (2010).","journal-title":"Neurobiol. Aging"},{"key":"841_CR95","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","volume":"10","author":"VR Osterberg","year":"2015","unstructured":"Osterberg, V. R. et al. Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of Parkinsonism. Cell Rep. 10, 1252\u20131260 (2015).","journal-title":"Cell Rep."},{"key":"841_CR96","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuroscience.2011.10.016","volume":"199","author":"Z Huang","year":"2011","unstructured":"Huang, Z., Xu, Z., Wu, Y. & Zhou, Y. Determining nuclear localization of alpha-synuclein in mouse brains. Neuroscience 199, 318\u2013332 (2011).","journal-title":"Neuroscience"},{"key":"841_CR97","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-016-0357-9","volume":"4","author":"NJ Rutherford","year":"2016","unstructured":"Rutherford, N. J., Brooks, M. & Giasson, B. I. Novel antibodies to phosphorylated \u03b1-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes. Acta Neuropathol. Commun. 4, 80 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"841_CR98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2003.09.075","volume":"354","author":"WL Lin","year":"2004","unstructured":"Lin, W. L., Delucia, M. W. & Dickson, D. W. \u03b1-Synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. Neurosci. Lett. 354, 99\u2013102 (2004).","journal-title":"Neurosci. Lett."},{"key":"841_CR99","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2990.2004.00564.x","volume":"30","author":"M Nishie","year":"2004","unstructured":"Nishie, M., Mori, F., Yoshimoto, M., Takahashi, H. & Wakabayashi, K. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol. Appl Neurobiol. 30, 546\u2013554 (2004).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"841_CR100","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.3390\/ijms232315294","volume":"23","author":"LJ Weston","year":"2022","unstructured":"Weston, L. J. et al. Aggregated Alpha-Synuclein inclusions within the nucleus predict impending neuronal cell death in a mouse model of Parkinsonism. Int. J. Mol. Sci. 23, 15294 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"841_CR101","doi-asserted-by":"crossref","unstructured":"Schaser, A. J. et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci. Rep. 9, 10919 (2019).","DOI":"10.1038\/s41598-019-47227-z"},{"key":"841_CR102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/hmg\/ddy326","volume":"28","author":"R Pinho","year":"2019","unstructured":"Pinho, R. et al. Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Hum. Mol. Genet. 28, 31\u201350 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"841_CR103","doi-asserted-by":"publisher","first-page":"1015881","DOI":"10.3389\/fnmol.2022.1015881","volume":"15","author":"Y Pan","year":"2022","unstructured":"Pan, Y. et al. Nuclear localization of alpha-synuclein affects the cognitive and motor behavior of mice by inducing DNA damage and abnormal cell cycle of hippocampal neurons. Front. Mol. Neurosci. 15, 1015881 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"841_CR104","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/ijms24032132","volume":"24","author":"DH Ho","year":"2023","unstructured":"Ho, D. H., Kim, H., Nam, D., Heo, J. & Son, I. Nuclear \u03b1-Synuclein-Derived cytotoxic effect via altered ribosomal RNA processing in primary mouse embryonic fibroblasts. Int. J. Mol. Sci. 24, 2132 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"841_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-024-00429-0","volume":"21","author":"T Du","year":"2024","unstructured":"Du, T. et al. Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration. Immun. Ageing 21, 1\u201316 (2024).","journal-title":"Immun. Ageing"},{"key":"841_CR106","doi-asserted-by":"publisher","first-page":"137490","DOI":"10.1016\/j.neulet.2023.137490","volume":"816","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits. Neurosci. Lett. 816, 137490 (2023).","journal-title":"Neurosci. Lett."},{"key":"841_CR107","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","volume":"10","author":"DJ Koss","year":"2022","unstructured":"Koss, D. J. et al. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathol. Commun. 10, 98 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"841_CR108","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1002\/cpcb.115","volume":"89","author":"M Hegazy","year":"2020","unstructured":"Hegazy, M. et al. Proximity ligation assay for detecting protein-protein interactions and protein modifications in cells and tissues in situ. Curr. Protoc. Cell Biol. 89, e115 (2020).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"841_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15885-6","volume":"7","author":"AMK Law","year":"2017","unstructured":"Law, A. M. K. et al. Andy\u2019s Algorithms: new automated digital image analysis pipelines for FIJI. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"841_CR110","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-9686-5_3","volume":"2040","author":"M L\u00f3pez-Cano","year":"2019","unstructured":"L\u00f3pez-Cano, M., Fern\u00e1ndez-Due\u00f1as, V. & Ciruela, F. Proximity ligation assay image analysis protocol: Addressing receptor-receptor interactions. Methods Mol. Biol. 2040, 41\u201350 (2019).","journal-title":"Methods Mol. Biol."},{"key":"841_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13039-017-0328-2","volume":"10","author":"L Debaize","year":"2017","unstructured":"Debaize, L., Jakobczyk, H., Rio, A. G., Gandemer, V. & Troadec, M. B. Optimization of proximity ligation assay (PLA) for detection of protein interactions and fusion proteins in non-adherent cells: application to pre-B lymphocytes. Mol. Cytogenet 10, 1\u201313 (2017).","journal-title":"Mol. Cytogenet"},{"key":"841_CR112","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/2211-5463.13110","volume":"11","author":"S L\u00f6vestam","year":"2021","unstructured":"L\u00f6vestam, S. et al. Seeded assembly in vitro does not replicate the structures of \u03b1-synuclein filaments from multiple system atrophy. FEBS Open Bio 11, 999\u20131013 (2021).","journal-title":"FEBS Open Bio"},{"key":"841_CR113","doi-asserted-by":"publisher","first-page":"RP92775","DOI":"10.7554\/eLife.92775.3","volume":"13","author":"SS Lee","year":"2024","unstructured":"Lee, S. S., Civitelli, L. & Parkkinen, L. Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. Elife 13, RP92775 (2024).","journal-title":"Elife"},{"key":"841_CR114","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson, E. et al. Proteasomal Inhibition by \u03b1-Synuclein Filaments and Oligomers. J. Biol. Chem. 279, 12924\u201312934 (2004).","journal-title":"J. Biol. Chem."},{"key":"841_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01131-8","volume":"9","author":"N Ferreira","year":"2021","unstructured":"Ferreira, N. et al. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. Acta Neuropathol. Commun. 9, 1\u201317 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"841_CR116","doi-asserted-by":"crossref","unstructured":"Ferreira, N. et al. Prodromal neuroinvasion of pathological \u03b1-synuclein in brainstem reticular nuclei and white matter lesions in a model of \u03b1-synucleinopathy. Brain Commun. 3, fcab104 (2021).","DOI":"10.1093\/braincomms\/fcab104"},{"key":"841_CR117","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nn.3041","volume":"15","author":"Y Shi","year":"2012","unstructured":"Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C. & Livesey, F. J. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15, 477\u2013486 (2012).","journal-title":"Nat. Neurosci."},{"key":"841_CR118","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.stemcr.2021.03.014","volume":"16","author":"CW Gantner","year":"2021","unstructured":"Gantner, C. W. et al. FGF-MAPK signaling regulates human deep-layer corticogenesis. Stem Cell Rep. 16, 1262\u20131275 (2021).","journal-title":"Stem Cell Rep."},{"key":"841_CR119","doi-asserted-by":"publisher","unstructured":"Rockenstein, E. et al. Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res. https:\/\/doi.org\/10.1002\/jnr.10231. (2002).","DOI":"10.1002\/jnr.10231"},{"key":"841_CR120","first-page":"1316","volume":"6","author":"MAS Baptista","year":"2013","unstructured":"Baptista, M. A. S. et al. A strategy for the generation, characterization and distribution of animal models by the Michael J. Fox Foundation for Parkinson\u2019s Research. Dis. Models Mech. 6, 1316\u20131324 (2013).","journal-title":"Dis. Models Mech."},{"key":"841_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16615","volume":"5","author":"N Ninkina","year":"2015","unstructured":"Ninkina, N. et al. A novel resource for studying function and dysfunction of \u03b1-synuclein: mouse lines for modulation of endogenous Snca gene expression. Sci. Rep. 5, 1\u20136 (2015).","journal-title":"Sci. Rep."},{"key":"841_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-020-00613-5","volume":"13","author":"VV Goloborshcheva","year":"2020","unstructured":"Goloborshcheva, V. V., Chaprov, K. D., Teterina, E. V., Ovchinnikov, R. & Buchman, V. L. Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive \u2018low footprint\u2019 genetic knockout of alpha-synuclein. Mol. Brain 13, 1\u20134 (2020).","journal-title":"Mol. Brain"},{"key":"841_CR123","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neurobiolaging.2016.06.020","volume":"46","author":"N Connor-Robson","year":"2016","unstructured":"Connor-Robson, N., Peters, O. M., Millership, S., Ninkina, N. & Buchman, V. L. Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. Neurobiol. Aging 46, 107\u2013112 (2016).","journal-title":"Neurobiol. Aging"},{"key":"841_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-32524-5","volume":"13","author":"KA Saal","year":"2023","unstructured":"Saal, K. A. et al. Heat denaturation enables multicolor X10-STED microscopy. Sci. Rep. 13, 1\u201315 (2023).","journal-title":"Sci. Rep."},{"key":"841_CR125","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nbt.3625","volume":"34","author":"PW Tillberg","year":"2016","unstructured":"Tillberg, P. W. et al. Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodies. Nat. Biotechnol. 34, 987\u2013992 (2016).","journal-title":"Nat. Biotechnol."},{"key":"841_CR126","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41596-018-0117-3","volume":"14","author":"S Truckenbrodt","year":"2019","unstructured":"Truckenbrodt, S., Sommer, C., Rizzoli, S. O. & Danzl, J. G. A practical guide to optimization in X10 expansion microscopy. Nat. Protoc. 14, 832\u2013863 (2019).","journal-title":"Nat. Protoc."},{"key":"841_CR127","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"841_CR128","first-page":"291","volume":"23","author":"AC Ruifrok","year":"2001","unstructured":"Ruifrok, A. C. & Johnston, D. A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291\u2013299 (2001).","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"841_CR129","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/bioinformatics\/btaa847","volume":"37","author":"G Landini","year":"2021","unstructured":"Landini, G., Martinelli, G. & Piccinini, F. Colour deconvolution: stain unmixing in histological imaging. Bioinformatics 37, 1485\u20131487 (2021).","journal-title":"Bioinformatics"},{"key":"841_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 1\u20137 (2017).","journal-title":"Sci. Rep."},{"key":"841_CR131","unstructured":"Allen Institute. Allen Brain Atlas: Mouse Brain. http:\/\/mouse.brain-map.org\/experiment\/thumbnails\/100142143?image_type=atlas (2008)."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00841-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00841-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00841-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:40:27Z","timestamp":1732902027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00841-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1038\/s41531-024-00841-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.08.602186","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}